Share
FRONTLINE Editor-in-Chief and Executive Producer Raney Aronson-Rath sits down with journalists and filmmakers for probing conversations about the investigative journalism that drives each FRONTLINE documentary and the stories that shape our time. Produced at FRONTLINE’s headquarters at GBH and powered by PRX. The FRONTLINE Dispatch is made possible by the Abrams Foundation Journalism Initiative.
…
continue reading
Manage episode 523273958 series 3290640
Content provided by Simon Wentworth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Simon Wentworth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
This week on the Podcast, we are joined by Dr Amr Hanbali.
During Blood Cancer Awareness Month, Guy Martin, news editor at The Pharma Letter, sat down with Dr Hanbali to discuss his experiences treating patients with CAR T-cell therapy in the Middle East.
With extensive experience in hematology and the treatment of blood disorders such as leukemia and myeloma, Dr Hanbali has been closely involved in expanding access to advanced therapies across the region.
Dr Hanbali discussed the evolution of blood cancer treatment in the Middle East, the unique challenges patients face in accessing cutting-edge therapies, and how CAR T-cell treatments are offering renewed hope for long-term remission.
He also shared his personal reflections on the impact of this therapy on patients and families, what needs to happen to improve regional access, and his vision for the future of blood cancer care in the next decade.
35 episodes
))
